Metabolic disturbances increasing the risk of coronary heart disease during diuretic-based antihypertensive therapy: Lipid alterations and glucose intolerance
- 30 November 1983
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 106 (5) , 1207-1214
- https://doi.org/10.1016/0002-8703(83)90176-x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Improvement of glucose tolerance and lowering of glycohemoglobin and serum lipid concentrations after discontinuation of antihypertensive drug therapy.Circulation, 1982
- “Less severe” hypertension: Should it be treated?American Heart Journal, 1981
- Glucosylation of human collagen in aging and diabetes mellitus.Journal of Clinical Investigation, 1980
- EFFECT OF PROPRANOLOL AND PRAZOSIN ON BLOOD LIPIDSThe Lancet, 1980
- Natural history of myocardial infarction in the coronary drug project: Long-term prognostic importance of serum lipid levelsThe American Journal of Cardiology, 1978
- HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.Circulation, 1977
- Multivariate prediction of coronary heart disease during 8.5 year follow-up in the western collaborative group studyPublished by Elsevier ,1976
- INCREASE IN SERUM-LIPIDS DURING TREATMENT OF HYPERTENSION WITH CHLORTHALIDONEThe Lancet, 1976
- THE PROBLEM OF TISSUE OXYGENATION IN DIABETES MELLITUSActa Medica Scandinavica, 1975
- BODY CHOLESTEROL METABOLISM IN MAN. I. THE EQUILIBRATION OF SERUM AND TISSUE CHOLESTEROL*†Journal of Clinical Investigation, 1962